ConductScience.org, home

Paper35397010

Involvement of BglG in Lipopolysaccharides (LPS) Synthesis and Transport in Stationary Phase in E. coli.

Vashishtha K and 2 others. Curr Microbiol, 2022. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Involvement of BglG in Lipopolysaccharides (LPS) Synthesis and Transport in Stationary Phase in E. coli. Papers, record 35397010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35397010

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Involvement of BglG in Lipopolysaccharides (LPS) Synthesis and Transport in Stationary Phase in E. coli.
PubMed
Journal
Curr Microbiol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.4
iCite
Revised in PubMed
2026-10-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vashishtha KKartika
2Shukla SShambhavi
3Mahadevan SSubramonyhttps://orcid.org/0000-0002-1367-224X

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Escherichia coliMajor topic
Escherichia coli ProteinsMajor topic
Bacterial Proteins
Gene Expression Regulation, Bacterial
Lipopolysaccharides
RNA
RNA-Binding Proteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
DBT-IISc Partenship ProgramDepartment of Biotechnology , Ministry of Science and TechnologyPubMed

Source PubMed

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116291664Mutations that activate the silent bgl operon of Escherichia coli confer a growth advantage in stationary phase.J Bacteriol2005https://conductscience.org/library/papers/16291664PubMed
219346244Escherichia coli K-12 Suppressor-free Mutants Lacking Early Glycosyltransferases and Late Acyltransferases: minimal lipopolysaccharide structure and induction of envelope stress response.J Biol Chem2009https://conductscience.org/library/papers/19346244PubMed
32673534Protein phosphorylation regulates transcription of the beta-glucoside utilization operon in E. coli.Cell1989https://conductscience.org/library/papers/2673534PubMed
410383761The response to stationary-phase stress conditions in Escherichia coli: role and regulation of the glutamic acid decarboxylase system.Mol Microbiol1999https://conductscience.org/library/papers/10383761PubMed
51279678Specificity determinants and structural features in the RNA target of the bacterial antiterminator proteins of the BglG/SacY family.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1279678PubMed
618546601Analyzing real-time PCR data by the comparative C(T) method.Nat Protoc2008https://conductscience.org/library/papers/18546601PubMed
72846278Regulation of the bgl operon of Escherichia coli by transcriptional antitermination.EMBO J1988https://conductscience.org/library/papers/2846278PubMed
810829079One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.Proc Natl Acad Sci U S A2000https://conductscience.org/library/papers/10829079PubMed
99721321In vivo expression of the beta-glucoside (bgl) operon of Escherichia coli occurs in mouse liver.J Bacteriol1998https://conductscience.org/library/papers/9721321PubMed
103301003A bacterial gene involved in transcription antitermination: regulation at a rho-independent terminator in the bgl operon of E. coli.Cell1987https://conductscience.org/library/papers/3301003PubMed
1120513705A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli.J Antimicrob Chemother2010https://conductscience.org/library/papers/20513705PubMed
121698125Transcriptional antitermination in the bgl operon of E. coli is modulated by a specific RNA binding protein.Cell1990https://conductscience.org/library/papers/1698125PubMed
137681219Microbial competition: Escherichia coli mutants that take over stationary phase cultures.Science1993https://conductscience.org/library/papers/7681219PubMed
142195546
Beta-glucoside permease represses the bgl operon of Escherichia coli by phosphorylation of the antiterminator protein and also interacts with glucose-specific enzyme III, the key element in catabolite control.
Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2195546PubMed
1511426055The Escherichia coli antiterminator protein BglG stabilizes the 5'region of the bgl mRNA.J Biosci2001https://conductscience.org/library/papers/11426055PubMed
164616943Regulation of the beta-glucoside system in Escherchia coli K-12.J Bacteriol1974https://conductscience.org/library/papers/4616943PubMed
1718793199Enhanced expression of the bgl operon of Escherichia coli in the stationary phase.FEMS Microbiol Lett2008https://conductscience.org/library/papers/18793199PubMed
1812694615Regulatory network of acid resistance genes in Escherichia coli.Mol Microbiol2003https://conductscience.org/library/papers/12694615PubMed
1922020646The β-glucoside (bgl) operon of Escherichia coli is involved in the regulation of oppA, encoding an oligopeptide transporter.J Bacteriol2012https://conductscience.org/library/papers/22020646PubMed
2032130434Catabolism of aromatic β-glucosides by bacteria can lead to antibiotics resistance.Arch Microbiol2020https://conductscience.org/library/papers/32130434PubMed

See all 32 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41830981Challenging the fitness cost: expression of the cryptic E. coli bgl operon lacks a measurable growth disadvantage in exponential phase.Arch Microbiol2026https://conductscience.org/library/papers/41830981PubMed
41188213RNA-binding antiterminators: regulation of metabolism and pathogenicity in bacteria.RNA Biol2025https://conductscience.org/library/papers/41188213PubMed
38761182Coaggregated E. faecalis with F. nucleatum regulated environmental stress responses and inflammatory effects.Appl Microbiol Biotechnol2024https://conductscience.org/library/papers/38761182PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35397010

GET https://conductscience.org/api/papers/v1/35397010/references?page=2